Quote this publication Share Print

NORDITROPIN SIMPLEXX and NORDIFLEX

-
Opinions on drugs - Posted on Apr 02 2013

Reason for request

Renewal of inclusion on the list of proprietary medicinal products refundable by National Health Insurance.

-


Actual benefit

Modéré

The absolute benefit of NORDITROPIN in adults with GH deficiency remains moderate.

Important

The actual benefit of NORDITROPIN in children with GH deficiency remains substantial.

The actual benefit of NORDITROPIN in Turner syndrome remains substantial.

The actual benefit of NORDITROPIN in chronic renal impairment remains substantial.

Faible

The actual benefit of NORDITROPIN in children born small for gestational age with a birth weight and/or height < -2 SD, who have failed to show catch-up growth (growth velocity < 0 SD during the last year) by 4 years of age or later and whose growth retardation (current height) is below or equal to -3 SD and the adjusted parental height < -1 SD remains low.


Contact Us

Évaluation des médicaments

See also